KUCHING: The healthcare sector has been projected to record admissions recovery in the second half (2H) of the year, driven by the rescheduling of appointments.
The research arm of Hong Leong Investment Bank Bhd (HLIB Research) expected patients deferring treatments during the Movement Control Order (MCO) would slowly schedule in appointments and drive up admissions in 2H.
“While hospitals were operational during MCO, patients were seemingly delaying non-urgent treatments with the fear of Covid-19,” HLIB Research said.
“This was seen in both KPJ Healthcare Bhd (KPJ) and IHH Healthcare Bhd (IHH), where utilisation rates have on average, fallen by more than 50 per cent during MCO.
“We are expecting some recovery in 2H, with assumption people will be less stigmatised to be near hospitals and schedule in appointments that will recover admissions.
“While it is still early in the Recovery MCO (RMCO), both KPJ and IHH has seen increasing number of patients enquiring to schedule in treatments.”
HLIB Research noted that the increase in admission in 2H should be further aided with the consent given to restart healthcare tourism.
The research arm recalled that during MCO, healthcare tourism in Malaysia has come to a halt with foreign tourists being banned from entering the country.
To note, Malaysia healthcare tourism accounted for five per cent to six per cent of total revenue in financial year 2019 (FY19) for KPJ and IHH.
“The recent announcement on the reopening borders for medical tourist in RMCO gives us hope for some recovery to be seen in 2H.”
HLIB Research highlighted that new standard operating procedures (SOPs) must be adhered with the relaxation.
It noted that under phase 1A, only critical patients requiring intensive care in Intensive Care Unit (ICU) or High Dependency Unit (HDU) are allowed.
For phase 1B, the relaxation will allow medical travellers who have critical health problems such as cancer (oncology) and heart (cardiology).
“Medical travellers will need to register with the Malaysia Healthcare Travel Council (MHTC) and undergo a Covid-19 screening test in their home country prior to arriving in Malaysia.
“Under the first phase, medical travellers would only be allowed to be accompanied by one chaperone through the entire course of treatment, while minor patients would be allowed with two caregivers.
“Hence, we are positive that some recovery will be witnessed on this front in 2H20.”
Source: The Borneo Post
shahizam.f@mhtc.org.my
Muhammad Rasydan Ma’at
Asst. Manager, Communications
+603 8776 6168
rasydan.m@mhtc.org.my
Malaysia Healthcare Travel Council (MHTC), established in 2009 under the purview of the Ministry of Health (MOH) Malaysia, is entrusted with developing and nurturing the “Malaysia Healthcare” brand. MHTC enhances, coordinates, and promotes Malaysia’s healthcare travel industry by fostering industry collaborations and building valuable public-private partnerships both domestically and internationally. With 80 member hospitals nationwide, MHTC continues to elevate the healthcare travel ecosystem through strong branding, seamless patient experiences, and strategic market initiatives. In line with these efforts, MHTC is spearheading the Malaysia Year of Medical Tourism (MYMT) 2026, the nation’s first dedicated year to celebrate and advance healthcare travel. MYMT 2026 serves as a milestone initiative to showcase Malaysia’s world-class healthcare offerings, strengthen its position as the premier global healthcare destination, and highlight the industry’s significant contribution to the national economy. More information can be found at https://www.mhtc.org.my/.
